HAV continues to cause preventable infection, outbreaks, and serious illness—often in populations with low immunity. Transmission risk is especially high among individuals experiencing homelessness and those with substance use disorders². Appropriate diagnostic testing in symptomatic individuals and immunity assessment when clinically indicated can support timely case identification, guide vaccination decisions, and aid in outbreak response efforts.
The Centers for Disease Control and Prevention (CDC) recommends hepatitis testing for individuals who meet one or more of the following criteria:3
Patients presenting with signs or symptoms consistent with viral hepatitis
Individuals with known or suspected exposure to hepatitis viruses
Patients requiring immunity assessment prior to international travel³
Labcorp offers guideline-aligned hepatitis testing panels designed to support appropriate screening, diagnosis, and disease monitoring. Automated reflex testing pathways help streamline the diagnostic process by advancing patients from screening to confirmatory testing without requiring additional provider orders. With broad national access and expert interpretive support, clinicians receive clear and actionable insights to guide patient management.
Labcorp simplifies hepatitis testing workflows through efficient ordering processes and integrated electronic health record connectivity. These capabilities reduce administrative burden for clinical staff while enabling timely result reporting. A nationwide network of patient service centers ensures convenient specimen collection and consistent access to testing.
Comprehensive hepatitis testing solutions help health systems expand screening programs and support population health initiatives. Earlier detection and prompt linkage to care facilitate more timely intervention, which may help reduce progression to advanced liver disease and long-term
